Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Preclinical results for DC101 presented at AACR

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Alnorin reported in phase I

April 19, 1996

BR96 produced successfully in milk from transgenic goats

April 12, 1996

Virulizin clinical trials resume in pancreatic cancer

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

MAbs for treatment of melanoma

April 5, 1996

IDEC-C2B8 development update

March 15, 1996

Virogenetics cancer vaccine in phase I/II trials

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...